Consuelo Arteaga de Murphy

Biokinetics of 99mTc-UBI 29-41 in humans

Laura Meléndez‐Alafort, J. Rodríguez-Cortés, Guillermina Ferro‐Flores et al. · Nuclear Medicine and Biology · 2004 · 83 citations

Radiation Oncology, Human Cell, Nuclear Medicine +1

In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria

Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy, Martha Pedraza-López et al. · Nuclear Medicine and Biology · 2003 · 81 citations

99Mtc-ubi Specificity, Medical Microbiology, Bacteriology +5

99mTc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection

Blanca Ocampo‐García, Flor de Marı́a Ramı́rez, Guillermina Ferro‐Flores et al. · Nuclear Medicine and Biology · 2010 · 75 citations

Nanoparticles, Nanomedicine, Engineering +6

Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours

Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy, Jeanette Rodr ́guez-Corte ́s et al. · Nuclear Medicine Communications · 2006 · 64 citations

Design, preparation, in vitro and in vivo evaluation of 99mTc-N2S2-Tat(49–57)-bombesin: A target-specific hybrid radiopharmaceutical

Clara Santos‐Cuevas, Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy et al. · International Journal of Pharmaceutics · 2009 · 55 citations

Engineering, Vivo Evaluation, Medicine +7